WHO: Indian strain of COVID-19 resistant to antibodies
Mutations of the Indian strain of COVID-19 indicate its high infectivity and resistance to antibodies in both those who have been ill and vaccinated, the World Health Organization reported.
New varieties of the virus have been discovered in India, including B.1.617. It is a variant with mutations E484Q and L452R that was first identified in India from samples collected on December 1, 2020.
According to preliminary research results, the L452R mutation may interfere with the effectiveness of certain monoclonal antibody treatments. E484Q can neutralize antibodies. Thus, the antibodies that have appeared in a person who has recovered from COVID-19 will not help in the fight against Indian mutations.
Moreover, the new strain is also thought to be highly virulent, which means it is more likely to infect and cause disease.
WHO experts have not yet figured out what influenced the virus mutations in India. One of the factors could be the holding of mass events that increased its spread, as well as the mitigation of antiquated measures in the country.
IDBank and Idram Hold Financial Literacy Session for Young Chess Players
Ucom – Main Sponsor of the 21st International Microelectronics Olympiad
Ucom and Republican Union of Employers of Armenia Sign Cooperation Memorandum
Ucom Service Center in Artashat Reopens at a New Address
Bratislava forum to debate Armenia’s strategic future
Create your Visa Digital from Unibank for purchases and transfers
Converse Bank Expands Its International Capabilities Through Cooperation with Citibank N.A.
Business loan pre-approval in five minutes — what did Unibank showcase in Gyumri?
Converse Bank Expands Its International Capabilities Through Cooperation with Citibank N.A.
35% Discount for the 35th Anniversary on Selected IDBank Cards